Penserra Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,088
| Closed | -$143K | – | 1338 |
|
|
2023
Q4 | $143K | Sell |
1,088
-5,280
| -83% | -$694K | ﹤0.01% | 835 |
|
|
2023
Q3 | $716K | Buy |
+6,368
| New | +$716K | 0.01% | 424 |
|
|
2020
Q3 | – | Sell |
-8,162
| Closed | -$995K | – | 999 |
|
|
2020
Q2 | $995K | Buy |
+8,162
| New | +$995K | 0.05% | 271 |
|
|
2019
Q1 | – | Sell |
-1,216
| Closed | -$86K | – | 775 |
|
|
2018
Q4 | $86K | Buy |
+1,216
| New | +$86K | 0.01% | 389 |
|